Answers are grounded in this paper and cite their sources.
There is an interest in developing topical pain relievers with bioactive agents including transient receptor channel (TRP) agonists. TRP channels are located on the endings of C-nociceptive nerve fibers and release local vasodilators while transmitting innocuous/noxious temperature signals that override A-delta nociceptive pain signals. Innocuous cold (≥25-28°C) and menthol activate TRPM8, innocuous warm (≥34-38°C) and camphor activate TRPV3, and noxious heat (>42°C) and capsaicin activate TRPV1. We hypothesized that combining menthol, capsaicin, and camphor would synergistically increase skin blood flow and decrease pain perception. In a randomized, double-blind, vehicle-controlled design nine participants (5 M/4 M; 22 [3.2] yrs), had compounded topical creams applied to a 52cm^2 area on both forearms including vehicle, 10% menthol, 0.05% capsaicin, 6% camphor, triple action, and no cream. On one forearm, skin blood flow (SkBF) was measured during a slow local heating protocol where temperature was increased at a rate of 1.0°C every 5 minutes 33-39°C. On the other forearm, the pain pressure threshold (PPT) was measured every 15 minutes for 2 hours with an algometer on the muscle belly of the flexor carpi radialis. Participants rated thermal sensation (scale -3 to 3) and thermal comfort (scale -2 to 2) every 5 minutes for 2 hours. There was an effect of TRP agonist treatment (p< 0.0001) and time (p< 0.0001) for all outcome measures. During local heating there was also an effect of temperature (p< 0.0001). There were no differences between vehicle and no cream treatments for any outcome measure (p>0.05). The menthol and the capsaicin treatments increased SkBF during slow local heating at 35°C-38°C (all p< 0.01) and 34°C-38°C (all p< 0.05), respectively, compared to vehicle/no cream. All creams containing TRP bioactive agents decreased PPT compared to vehicle/no cream: menthol: 15, 45, and 60 (all p< 0.05); capsaicin: 45, 60, and 90 (all p< 0.05); camphor 30-90 (all p< 0.05); triple action: 15, 45, 75, and 90 (all p< 0.05) min. For all TRP bioactive creams there was a treatment x time effect (p< 0.0001) for the thermal sensation. The menthol and triple action were rated as cooler and the capsaicin was rated as warmer than the vehicle/no cream: menthol: 5-65 (all p< 0.05); capsaicin: 50-65 and 75-80 (all p< 0.05); triple action: 5-95 (all p< 0.05) min. The menthol, capsaicin, and triple action were rated at levels of comfort different than the vehicle/no cream: menthol: 5-45 (all p< 0.05); capsaicin: 5-120 (all p< 0.05); triple action: 5-75, 100, and 110 (all p< 0.05) min. Combining the TRP agonists menthol, capsaicin, and camphor inhibited cutaneous vasodilation throughout local skin heating, likely through a competitive inhibition of the TRP receptors. The triple action was equally effective at reducing the PPT. Menthol produced cooler sensations and capsaicin produced warmer sensations while camphor was neutral. The triple action produced cold sensations and was perceived as slightly less comfortable than the vehicle/no cream, but not uncomfortable. These findings show that this topical combination of menthol, capsaicin, and camphor ensures TRP activation and maximizes pain relief. Funded by Reckitt Benckiser Inc. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
McKenna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: